A carregar...
The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes
Antiadhesion molecules are effective and safe in patients with ulcerative colitis (UC). Etrolizumab, a monoclonal antibody targeting both α(4)β(7) and α(E)β(7), represents a promising therapy for patients with UC, since this novel mechanism of action may be effective in blocking leukocyte recruitmen...
Na minha lista:
| Publicado no: | Therap Adv Gastroenterol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913345/ https://ncbi.nlm.nih.gov/pubmed/27366219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16647935 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|